Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2020 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 20 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells

  • Authors:
    • Alma Y. Parra‑Torres
    • Juana Enríquez
    • Rogelio F. Jiménez‑Ortega
    • Nelly Patiño
    • Manuel De Jesús Castillejos‑López
    • Luz M. Torres‑Espíndola
    • Eric G. Ramírez‑Salazar
    • Rafael Velázquez‑Cruz
  • View Affiliations / Copyright

    Affiliations: Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City 14610, Mexico, Department of Reproduction Biology Carlos Gual Castro, National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ), Mexico City 14080, Mexico, Subdirection of Clinical Applications Development, National Institute of Genomic Medicine (INMEGEN), Mexico City 14610, Mexico, Epidemiological Surveillance Unit, National Institute of Respiratory Diseases (INER) ‘Ismael Cosío Villegas’, Mexico City 14080, Mexico, Pharmacology Laboratory, National Institute of Pediatrics (INP), Mexico City 04530, Mexico, National Council for Science and Technology (CONACYT)‑National Institute of Genomic Medicine (INMEGEN), Mexico City 14610, Mexico
    Copyright: © Parra‑Torres et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 254
    |
    Published online on: October 23, 2020
       https://doi.org/10.3892/etm.2020.9384
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Bone formation is a dynamic process directed by osteoblast activity. The transition from the proliferation to differentiation stage during osteoblast maturation involves the downregulation of the Wnt/β‑catenin signaling pathway, and extracellular antagonists are important for the regulation of Wnt signaling. However, the expression levels of Wnt antagonists in these stages of human osteoblast maturation have not been fully elucidated. Therefore, the aim of the present study was to investigate the expression levels of extracellular Wnt antagonists during proliferation and differentiation in osteoblast‑like cell lines. The results demonstrated an overlap between the differential expression of secreted Frizzled‑related protein (SFPR)2, SFRP3, SFRP4 and Dickkopf (DKK) 2 genes during the differentiation stage in the MG‑63 and Saos‑2 cells. Furthermore, high expression levels of DKK3 in MG‑63 cells, Wnt inhibitory factor 1 (WIF1) in Saos‑2 cells and DKK4 in hFOB 1.19 cells during the same stage (differentiation), were observed. The upregulated expression levels of Wnt antagonists were also correlated with the high expression of anxin 2 during the differentiation stage. These findings suggested that Wnt‑related antagonists could modulate the Wnt/β‑catenin signaling pathway. By contrast, DKK1 was the only gene that was found to be upregulated during the proliferation stage in hFOB 1.19 and Saos‑2 cells. To the best of our knowledge, the present study provides, for the first time, the expression profile of Wnt antagonists during the proliferation stage and the initial phases of differentiation in osteoblast‑like cell lines. The current results offer a basis to investigate potential targets for bone‑related Wnt‑signaling modulation in bone metabolism research.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Raggatt LJ and Partridge NC: Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 285:25103–25108. 2010.PubMed/NCBI View Article : Google Scholar

2 

Karner CM and Long F: Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci. 74:1649–1657. 2017.PubMed/NCBI View Article : Google Scholar

3 

Kobayashi Y, Uehara S, Udagawa N and Takahashi N: Regulation of bone metabolism by Wnt signals. J Biochem. 159:387–392. 2016.PubMed/NCBI View Article : Google Scholar

4 

Boudin E, Fijalkowski I, Piters E and Van Hul W: The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin Arthritis Rheum. 43:220–240. 2013.PubMed/NCBI View Article : Google Scholar

5 

Nusse R and Clevers H: Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 169:985–999. 2017.

6 

Jho E, Zhang T, Domon C, Joo CK, Freund JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the transcription of axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 22:1172–1183. 2002.PubMed/NCBI View Article : Google Scholar

7 

Bodine PVN, Zhao W, Kharode YP, Bex FJ, Lambert AJ, Goad MB, Gaur T, Stein GS, Lian JB and Komm BS: The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 18:1222–1237. 2004.PubMed/NCBI View Article : Google Scholar

8 

Morvan F, Boulukos K, Clément-Lacroix P, Roman SR, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho S, Pognonec P, et al: Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res. 21:934–945. 2006.PubMed/NCBI View Article : Google Scholar

9 

Cho SW, Her SJ, Sun HJ, Choi OK, Yang JY, Kim SW, Kim SY and Shin CS: Differential effects of secreted frizzled-related proteins (sFRPs) on osteoblastic differentiation of mouse mesenchymal cells and apoptosis of osteoblasts. Biochem Biophys Res Commun. 367:399–405. 2008.PubMed/NCBI View Article : Google Scholar

10 

Cho SW, Yang JY, Sun HJ, Jung JY, Her SJ, Cho HY, Choi HJ, Kim SW, Kim SY and Shin CS: Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone. 44:1069–1077. 2009.PubMed/NCBI View Article : Google Scholar

11 

van der Horst G, van der Werf SM, Farih-Sips H, van Bezooijen RL, Löwik CWGM and Karperien M: Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res. 20:1867–1877. 2005.PubMed/NCBI View Article : Google Scholar

12 

Sims AM, Shephard N, Carter K, Doan T, Dowling A, Duncan EL, Eisman J, Jones G, Nicholson G, Prince R, et al: Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. J Bone Miner Res. 23:499–506. 2008.PubMed/NCBI View Article : Google Scholar

13 

Fujita M, Urano T, Shiraki M, Momoeda M, Tsutsumi O, Hosoi T, Clinic K, Orimo H, Ouchi Y and Inoue S: Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density. Geriatrics Gerontol Int. 4:175–180. 2004.

14 

Maehata Y, Takamizawa S, Ozawa S, Kato Y, Sato S, Kubota E and Hata RI: Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: Roles of osterix, an osteoblast-related transcription factor. Matrix Biol. 25:47–58. 2006.PubMed/NCBI View Article : Google Scholar

15 

Coelho MJ and Fernandes MH: Human bone cell cultures in biocompatibility testing. Part II: Effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 21:1095–1102. 2000.PubMed/NCBI View Article : Google Scholar

16 

Harris SA, Enger RJ, Riggs LB and Spelsberg TC: Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res. 10:178–186. 1995.PubMed/NCBI View Article : Google Scholar

17 

Kapinas K, Kessler C, Ricks T, Gronowicz G and Delany AM: miR-29 modulates wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem. 285:25221–25231. 2010.PubMed/NCBI View Article : Google Scholar

18 

Waterborg JH and Matthews HR: The lowry method for protein quantitation. Methods Mol Biol. 1:1–3. 1984.PubMed/NCBI View Article : Google Scholar

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

20 

Hoemann CD, El-Gabalawy H and McKee MD: In vitro osteogenesis assays: Influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol (Paris). 57:318–323. 2009.PubMed/NCBI View Article : Google Scholar

21 

Landim de Barros T, Brito VGB, do Amaral CCF, Chaves-Neto AH, Campanelli AP and Oliveira SHP: Osteogenic markers are reduced in bone-marrow mesenchymal cells and femoral bone of young spontaneously hypertensive rats. Life Sci. 146:174–183. 2016.PubMed/NCBI View Article : Google Scholar

22 

Kerekes K, Bányai L, Trexler M and Patthy L: Structure, function and disease relevance of Wnt inhibitory factor 1, a secreted protein controlling the Wnt and hedgehog pathways. Growth Factors. 37:29–52. 2019.PubMed/NCBI View Article : Google Scholar

23 

Rubin EM, Guo Y, Tu K, Xie J, Zi X and Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma. Mol Cancer Ther. 9:731–741. 2010.PubMed/NCBI View Article : Google Scholar

24 

Stein GS, Lian JB and Owen TA: Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:3111–3123. 1990.PubMed/NCBI View Article : Google Scholar

25 

Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB and Stein GS: Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 143:420–430. 1990.PubMed/NCBI View Article : Google Scholar

26 

Enríquez J, Lemus AE, Chimal-Monroy J, Arzate H, García GA, Herrero B, Larrea F and Pérez-Palacios G: The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites. J Endocrinol. 193:493–504. 2007.PubMed/NCBI View Article : Google Scholar

27 

Vaes BL, Dechering KJ, van Someren EP, Hendriks JM, van de Ven CJ, Feijen A, Mummery CL, Reinders MJ, Olijve W, van Zoelen EJ and Steegenga WT: Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone. 36:803–811. 2005.PubMed/NCBI View Article : Google Scholar

28 

Eijken M, Meijer IMJ, Westbroek I, Koedam M, Chiba H, Uitterlinden AG, Pols HAP and van Leeuwen JPTM: Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem. 104:568–579. 2008.PubMed/NCBI View Article : Google Scholar

29 

von Marschall Z and Fisher LW: Secreted frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun. 400:299–304. 2010.PubMed/NCBI View Article : Google Scholar

30 

Chung YS, Baylink DJ, Srivastava AK, Amaar Y, Tapia B, Kasukawa Y and Mohan S: Effects of secreted frizzled-related protein 3 on osteoblasts in vitro. J Bone Miner Res. 19:1395–1402. 2004.PubMed/NCBI View Article : Google Scholar

31 

Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, Hurley M, Guo C, Boskey A, Sun L, et al: Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet. 37:945–952. 2005.PubMed/NCBI View Article : Google Scholar

32 

Baker EK, Taylor S, Gupte A, Chalk AM, Bhattacharya S, Green AC, Martin TJ, Strbenac D, Robinson MD, Purton LE and Walkley CR: Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma. Bone. 73:223–232. 2015.PubMed/NCBI View Article : Google Scholar

33 

Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, Kolb EA, Mazza BA, Meyers PA and Gorlick R: Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res. 64:2734–2739. 2004.PubMed/NCBI View Article : Google Scholar

34 

Aslan H, Ravid-Amir O, Clancy BM, Rezvankhah S, Pittman D, Pelled G, Turgeman G, Zilberman Y, Gazit Z, Hoffmann A, et al: Advanced molecular profiling in vivo detects novel function of dickkopf-3 in the regulation of bone formation. J Bone Miner Res. 21:1935–1945. 2006.PubMed/NCBI View Article : Google Scholar

35 

Hiramitsu S, Terauchi M and Kubota T: The effects of dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts. Endocrinology. 154:4618–4626. 2013.PubMed/NCBI View Article : Google Scholar

36 

Tang Q, Zhao H, Yang B, Li L, Shi Q, Jiang C and Liu H: WIF1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis. Oncol Lett. 13:1183–1188. 2017.PubMed/NCBI View Article : Google Scholar

37 

Yan Y, Tang D, Chen M, Huang J, Xie R, Jonason JH, Tan X, Hou W, Reynolds D, Hsu W, et al: Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci. 122:3566–3578. 2009.PubMed/NCBI View Article : Google Scholar

38 

Gregory CA, Singh H, Perry AS and Prockop DJ: The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem. 278:28067–28078. 2003.PubMed/NCBI View Article : Google Scholar

39 

Nakasa T, Yoshizuka M, Andry Usman M, Elbadry Mahmoud E and Ochi M: MicroRNAs and bone regeneration. Curr Genomics. 16:441–452. 2015.PubMed/NCBI View Article : Google Scholar

40 

Wang J, Liu S, Li J, Zhao S and Yi Z: Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells. Stem Cell Res Ther. 10(197)2019.PubMed/NCBI View Article : Google Scholar

41 

Lin ZW, Zhang W, Jiang SD, Wei WB and Li XF: Inhibition of microRNA-940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled-related protein 1-mediated Wnt/β-catenin signaling pathway. J Cell Biochem: Oct 15, 2018 (Epub ahead of print). doi: 10.1002/jcb.27580.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Parra‑Torres AY, Enríquez J, Jiménez‑Ortega RF, Patiño N, Castillejos‑López MD, Torres‑Espíndola LM, Ramírez‑Salazar EG and Velázquez‑Cruz R: Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells. Exp Ther Med 20: 254, 2020.
APA
Parra‑Torres, A.Y., Enríquez, J., Jiménez‑Ortega, R.F., Patiño, N., Castillejos‑López, M.D., Torres‑Espíndola, L.M. ... Velázquez‑Cruz, R. (2020). Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells. Experimental and Therapeutic Medicine, 20, 254. https://doi.org/10.3892/etm.2020.9384
MLA
Parra‑Torres, A. Y., Enríquez, J., Jiménez‑Ortega, R. F., Patiño, N., Castillejos‑López, M. D., Torres‑Espíndola, L. M., Ramírez‑Salazar, E. G., Velázquez‑Cruz, R."Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells". Experimental and Therapeutic Medicine 20.6 (2020): 254.
Chicago
Parra‑Torres, A. Y., Enríquez, J., Jiménez‑Ortega, R. F., Patiño, N., Castillejos‑López, M. D., Torres‑Espíndola, L. M., Ramírez‑Salazar, E. G., Velázquez‑Cruz, R."Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells". Experimental and Therapeutic Medicine 20, no. 6 (2020): 254. https://doi.org/10.3892/etm.2020.9384
Copy and paste a formatted citation
x
Spandidos Publications style
Parra‑Torres AY, Enríquez J, Jiménez‑Ortega RF, Patiño N, Castillejos‑López MD, Torres‑Espíndola LM, Ramírez‑Salazar EG and Velázquez‑Cruz R: Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells. Exp Ther Med 20: 254, 2020.
APA
Parra‑Torres, A.Y., Enríquez, J., Jiménez‑Ortega, R.F., Patiño, N., Castillejos‑López, M.D., Torres‑Espíndola, L.M. ... Velázquez‑Cruz, R. (2020). Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells. Experimental and Therapeutic Medicine, 20, 254. https://doi.org/10.3892/etm.2020.9384
MLA
Parra‑Torres, A. Y., Enríquez, J., Jiménez‑Ortega, R. F., Patiño, N., Castillejos‑López, M. D., Torres‑Espíndola, L. M., Ramírez‑Salazar, E. G., Velázquez‑Cruz, R."Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells". Experimental and Therapeutic Medicine 20.6 (2020): 254.
Chicago
Parra‑Torres, A. Y., Enríquez, J., Jiménez‑Ortega, R. F., Patiño, N., Castillejos‑López, M. D., Torres‑Espíndola, L. M., Ramírez‑Salazar, E. G., Velázquez‑Cruz, R."Expression profiles of the Wnt/β‑catenin signaling‑related extracellular antagonists during proliferation and differentiation in human osteoblast‑like cells". Experimental and Therapeutic Medicine 20, no. 6 (2020): 254. https://doi.org/10.3892/etm.2020.9384
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team